Harrow Health, 11875 Stock Shares Owned By Insiders
| HROWM Stock | 26.24 0.14 0.54% |
Harrow Health, 11875 fundamentals help investors to digest information that contributes to Harrow Health,'s financial success or failures. It also enables traders to predict the movement of Harrow Stock. The fundamental analysis module provides a way to measure Harrow Health,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harrow Health, stock.
Harrow | Shares Owned By Insiders |
Harrow Health, 11875 Company Shares Owned By Insiders Analysis
Harrow Health,'s Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 0.0% of Harrow Health, 11875 are shares owned by insiders. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Specialty & Generic industry. The shares owned by insiders for all United States stocks is 100.0% higher than that of the company.
Harrow Health, Current Valuation Drivers
We derive many important indicators used in calculating different scores of Harrow Health, from analyzing Harrow Health,'s financial statements. These drivers represent accounts that assess Harrow Health,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health,'s important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 626.0M | 640.1M | 661.4M | 688.7M | 841.5M | 883.6M | |
| Enterprise Value | 642.0M | 659.4M | 697.2M | 704.7M | 957.9M | 1.0B |
About Harrow Health, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health, 11875's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health, 11875 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Harrow Health, Piotroski F Score and Harrow Health, Altman Z Score analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health,. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health, 11875 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health,'s value that differs from its market value or its book value, called intrinsic value, which is Harrow Health,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health,'s market value can be influenced by many factors that don't directly affect Harrow Health,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.